Related Experiment Video
Updated: May 26, 2026

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
Published on: June 6, 2020
Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line
Pavel Barta1, Jennie Malmberg, Ludmila Melicharova
1Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
Abstract:
Cell lines are common model systems in the development of therapeutic proteins and in the research on cellular functions and dysfunctions. In this field, the protein interaction assay is a frequently used tool for assessing the adequacy of a protein for diagnostic and therapeutic purposes. In this study, we investigated the extent to which the interaction characteristics depend on the choice of cell line for HER-family receptors. The interaction characteristics of two therapeutic antibodies (trastuzumab and cetuximab) and one Affibody molecule (ZHER2:342), interacting with the intended receptor were characterized with high precision using an automated real-time interaction method, in different cell lines (HaCaT, A431, HEP-G2, SKOV3, PC3, DU-145). Clear differences in binding affinity and kinetics, up to one order of magnitude, were found for the interaction of the same protein binding to the same receptor on different cells for all three proteins. For HER-family receptors, it is therefore important to refer to the measured affinity for a protein-receptor interaction together with the hosting cell line. The ability to accurately measure affinity and kinetics of a protein-receptor interaction on cell lines of different origins may increase the understanding of underlying receptor biology, and impact the selection of candidates in the development of therapeutic or diagnostic agents.
Insights
The choice of cell line significantly impacts the binding characteristics of therapeutic proteins targeting HER-family receptors. Accurate measurement of protein-receptor interactions requires specifying the cell line used for characterization.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Cell lines are crucial models for therapeutic protein development and cellular research.
- Protein interaction assays are vital for evaluating proteins for diagnostic and therapeutic applications.
- HER-family receptors are key targets in various diseases, necessitating precise characterization of their interactions.
Purpose of the Study:
- To investigate the influence of different cell lines on the interaction characteristics of HER-family receptor-targeting proteins.
- To precisely quantify binding affinity and kinetics of therapeutic antibodies and Affibody molecules.
- To determine if cell line choice affects the assessment of protein-receptor interactions.
Main Methods:
- Utilized an automated real-time interaction method for high-precision characterization.
- Tested three distinct proteins: trastuzumab, cetuximab, and ZHER2:342 Affibody molecule.
- Employed multiple human cell lines: HaCaT, A431, HEP-G2, SKOV3, PC3, and DU-145.
Main Results:
- Observed significant variations in binding affinity and kinetics (up to one order of magnitude) for the same protein-receptor interaction across different cell lines.
- These differences were consistent for all three tested proteins (trastuzumab, cetuximab, ZHER2:342).
- Demonstrated that cell line origin critically influences measured interaction parameters.
Conclusions:
- The selection of cell line is a critical factor that must be reported when characterizing HER-family receptor-protein interactions.
- Accurate affinity and kinetic measurements are dependent on the specific cell line used.
- Understanding cell line-specific interactions can enhance the selection of therapeutic and diagnostic agents and deepen insights into receptor biology.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Signal Transduction: Overview
Typically, signal transduction involves three...
Types of Receptors: Cell Surface Receptors
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

